COMPANY PROFILE

Synaptrix

Explore full profile

Drug-free pain management solutions for postoperative joint surgery with proprietary electrical stimulation technology

Alpharetta, United StatesFounded 2023Health Tech & Medtech

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Synaptrix

Synaptrix is a medical device startup focused on the development and commercialization of drug-free pain management solutions specifically designed for patients recovering from postoperative joint surgery. The company's flagship product, the NOVABLOC system, offers a procedure-based solution that utilizes a novel form of electrical stimulation to alleviate pain. This innovative approach has been validated through human feasibility studies, demonstrating the potential to provide up to 20 days of pain relief with a single treatment. Synaptrix primarily serves the healthcare sector, targeting hospitals and clinics that perform joint surgeries. The business model revolves around the sale and distribution of the NOVABLOC system to medical institutions, generating revenue through product sales and potential service agreements. By addressing the need for effective, non-pharmacological pain management, Synaptrix positions itself in a niche market with significant growth potential.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: Alpharetta, United States
Employees: 7
Open positions: None listed
Dealroom signal: 57.5/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, pain care, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Nov 2024	$10M	$40M	Avanos · Portal Innovations · Hatteras Venture Partners · Rex Health Ventures	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Synaptrix website traffic

Latest recorded traffic for Synaptrix is 2.1K monthly website visits, up 40% over the last three months. Synaptrix's team grew 133.3% over the past year.

Latest monthly visits2.1K 3-month web change+40% 1-year team growth+133.3%

Monthly website visitsDec 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SMStratus MedicalStratus Medical - Nimbus, Advancing RF Technology For the Treatment of Pain	Salt Lake City, United States	Operational	32	$35M	$40M
SISi-BoneDevelops an implant to tackle lower back pains	San Jose, United States	Operational
HTHuashu Turing Additive Manufacturing TechnologyMedical 3D printing solutions for clinical applications	Chengdu, China	Operational
ANAnthrotekHyper-realistic silicone anatomy for cross-industry applications	Newmarket, United Kingdom	Operational
SYSympheraA comprehensive surgical system streamlining minimally-invasive procedures for enhanced efficiency	Munich, Germany	Operational
APApproximaThe first minimally invasive treatment tailored for the tricuspid valve	Milan, Italy	Operational
OIOPTIMOTION IMPLANTSTHE NEXT GENERATION TOTAL KNEE REPLACEMENT	Orlando, United States	Operational
CUCustomSurgA medical device venture, founded by a multidisciplinary team of surgeons, biomechanics experts, and life sciences entrepreneurs from ETH Zurich and Harvard Medical School	Zurich, Switzerland	Operational